The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs

American Journal of Drug and Alcohol Abuse

Volumn 38, Issue 1, 2012, Pages 55-62

  Debeck, Kora ^a,b   Kerr, Thomas ^a,b   Lai, Calvin ^a   Buxton, Jane ^b   Montaner, Julio ^a,b   Wood, Evan ^a,b  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Injection drug use; Supervised injection facilities; Validity of willingness measures

Indexed keywords

ADULT; ARTICLE; FEMALE; HEALTH PROGRAM; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PATIENT ASSESSMENT; SAMPLE SIZE; SELF REPORT; SUPERVISED INJECTING FACILITIES;

ADULT; DRUG USERS; FEMALE; HOMELESS PERSONS; HUMANS; MALE; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84857536516     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2011.600389     Document Type: Article

References (44)

1. DeBeck K, Wood E, Montaner J, Kerr T. Canada's 2003 renewed drug strategy - An evidence-based review. HIV AIDS Policy Law Rev 2006; 11(2-3):1, 5-12.
2. Reuter P, Caulkins J. Redefining the goals of national drug policy: Recommendations from a working group. Am J Public Health 1995; 85(8 Pt 1):1059.
3. Rhodes T. The 'risk environment': A framework for understanding and reducing drug-related harm. Int J Drug Policy 2002; 13(2):85-94. (Pubitemid 34607323)
4. Wood E, Stoltz JA, Zhang R, Strathdee SA, Montaner JSG, Kerr T. Circumstances of first crystal methamphetamine use and initiation of injection drug use among high-risk youth. Drug Alcohol Rev 2008; 27(3):270-276.
5. Rowden D, Dorsey P, Bullman S, Lestina R, Han C, Herrell J. HIV outreach for hard-to-reach populations: A cross-site perspective. Eval Program Plann 1999; 22(3):251-258. (Pubitemid 29520183)
6. Vlahov D, Coady MH, Ompad DC, Galea S. Strategies for improving influenza immunization rates among hard-to-reach populations. J Urban Health 2007; 84(4):615-631. (Pubitemid 47075055)
7. Platt L,WallM, Rhodes T, Judd A, HickmanM, Johnston LG, Renton A, Bobrova N, Sarang A. Methods to recruit hard-toreach groups: Comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia. J Urban Health 2006; 83(6 Suppl.):i39-i53.
8. Wood E, Kerr T, Montaner J, Strathdee S, Wodak A, HankinsC, Schechter M, Tyndall M. Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet Infect Dis 2004; 4(5):301-306. (Pubitemid 38561228)
9. McCoy CB, Metsch LR, Chitwood DD, Miles C. Drug use andbarriers to use of health care services. Subst Use Misuse 2001; 36(6):789-804.
10. Strathdee SA, Palepu A, Cornelisse PGA, Yip B,O'Shaughnessy MV, Montaner JSG, Schechter M, Hogg R. Barriers to use of free antiretroviral therapy in injection drug users. J Am Med Assoc 1998; 280(6):547.
11. Edlin BR, Kresina TF, Raymond DB, CardenMR, Gourevitch MN, Rich JD, Cheever L, Cargill V. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 2005; 40(Suppl. 5):S276-S285. (Pubitemid 40490212)
12. Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, Hogg R, O'Shaughnessy M. The potential public health and community impacts of safer injecting facilities: Evidence from a cohort of injection drug users. JAIDS 2003; 32(1):2.
13. Wood E, Tyndall M, Montaner J, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ 2006; 175(11):1399-1404. (Pubitemid 44876560)
14. Coyne-Beasley T, Ford CA, Waller MW, Adimora AA, Resnick MD. Sexually active students' willingness to use school-based health centers for reproductive health care services in North Carolina. Ambul Pediatr 2003; 3(4):196-202. (Pubitemid 36949756)
15. Myklestad I, Rise J. Predicting willingness to engage in unsafesex and intention to perform sexual protective behaviors among adolescents. Health Educ Behav 2007; 34(4):686-699.
16. Gibbons FX, Gerrard M, Blanton H, Russell DW. Reasoned action and social reaction: Willingness and intention as independent predictors of health risk. J Pers Soc sychol 1998; 74(5):1164-1180. (Pubitemid 128656636)
17. Litchfield R, White K. Young adults' willingness and intentions to use amphetamines: An application of the theory of reasoned action. E J Appl Psychol 2006; 2(1):45-51.
18. Gerrard M, Gibbons FX, Stock ML, Lune LS, Cleveland MJ. Images of smokers and willingness to smoke among African American pre-adolescents: An application of the prototype/willingness model of adolescent health risk behavior to smoking initiation. J Pediatr Psychol 2005; 30(4):305-318. (Pubitemid 40629158)
19. Gibbons FX, Gerrard M, Lane DJ. A social reaction model of adolescent health risk. In Social Psychological Foundations of Health and Illness. Suls JM, Wallston KA, eds. Oxford: Blackwell, 2003; 107.
20. Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. CMAJ 2003; 169(8): 759.
21. Kral AH,Wenger L, Carpenter L,Wood E, Kerr T, Bourgois P. Acceptability of a safer injection facility among injection drug users in San Francisco. Drug Alcohol Depend 2010; 110(1- 2):160-163.
22. Hunt N, Lloyd C, Kimber J, Tompkins C. Public injecting and willingness to use a drug consumption room among needle exchange programme attendees in the UK. Int J Drug Policy 2007; 18(1):62-65. (Pubitemid 46240800)
23. O'Shea M. Introducing safer injecting facilities (SIFs) in the Republic of Ireland: 'Chipping away' at policy change. Drugs Educ Prev Policy 2007; 14(1):75-88.
24. Fry CL. Injecting drug user attitudes towards rules for supervised injecting rooms: Implications for uptake. Int J Drug Policy 2002; 13(6):471-476. (Pubitemid 35461962)
25. Fry C, Fox S, Rumbold G. Establishing safe injecting rooms in Australia: Attitudes of injecting drug users. Aust N Z J Public Health 2008; 23(5):501-504.
26. Van Beek I, Gilmour S. Preference to have used a medicallysupervised injecting centre among injecting drug users in Kings Cross, Sydney. Aust N Z J Public Health 2000; 24(5):540-542.
27. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, Montaner J, O'Shaughnessy M, Schechter M. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help? CMAJ 2001; 165(4):405-410. (Pubitemid 32885418)
28. Kerr T, Marshall A, Walsh J, Palepu A, Tyndall M, Montaner J, Hogg R, Wood E. Determinants of HAART discontinuation among injection drug users. AIDS Care 2005; 17(5):539-549. (Pubitemid 40979462)
29. Tyndall M, Kerr T, Zhang R, King E, Montaner J, Wood E. Attendance drug use patterns, and referrals made from North America's first supervised injection facility. Drug Alcohol Depend 2006; 83(3):193-198.
30. Maldonado G, Greenland S. Simulation study of confounderselection strategies. Am J Epidemiol 1993; 138(11):923-936.
31. Rothman KJ, Greenland S. Modern Epidemiology. New York: Lippincott Williams & Wilkins, 1998.
32. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73(1):13.
33. Armitage CJ, Conner M. Efficacy of the theory of planned behaviour: A meta-analytic review. Br J Soc Psychol 2001; 40(Pt 4):471-499. (Pubitemid 33597358)
34. Hukkelberg SS, Dykstra JL. Using the prototype/willingness model to predict smoking behaviour among Norwegian adolescents. Addict Behav 2009; 34(3):270-276.
35. Albarracin D, Johnson BT, Fishbein M, Muellerleile PA. Theories of reasoned action and planned behavior as models of condom use: A meta-analysis. Psychol Bull 2001; 127(1):142-161. (Pubitemid 33604027)
36. Sheeran P, Orbell S. Do intentions predict condom use? Metaanalysis and examination of six moderator variables. Br J Soc Psychol 1998; 37(Pt 2):231-250. (Pubitemid 128457317)
37. Fisher WA, Fisher JD, Rye BJ. Understanding and promoting AIDS-preventive behavior: Insights from the theory of reasoned action. Health Psychol 1995; 14(3):255-264.
38. Wood E, Tyndall M, Li K, Lloyd-Smith E, SmallW,Montaner J, Kerr T. Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med 2005; 29(2):126-130. (Pubitemid 40991183)
39. Petrar S, Kerr T, Tyndall MW, Zhang R, Montaner JS, Wood E. Injection drug users' perceptions regarding use ofa medically supervised safer injecting facility. Addict Behav 2007; 32(5):1088-1093. (Pubitemid 46282298)
40. Fast D, Shoveller J, Shannon K, Kerr T. Safety and danger in downtown Vancouver: Understandings of place among young people entrenched in an urban drug scene. Health Place 2010; 16(1):51-60.
41. Jürgens R. Nothing about Us without Us: Greater, Meaningful Involvement of People Who Use Illegal Drugs: A Public Health, Ethical and Human Rights Imperative. Toronto, ON, Canada: Canadian HIV/AIDS Legal Network, 2005.
42. Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh D, Montaner J, Tyndall M. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J 2004; 1(9): 1-5.
43. Tyndall MW, Craib KJP, Currie S, Li K, O'Shaughnessy MV, Schechter MT. Impact of HIV infection on mortality in a cohort of injection drug users. JAIDS 2001; 28(4): 351.
44. DeBeck K, Kerr T, Li K, Fischer B, Buxton J, Montaner J, Wood E. Emergence of crack cocaine smoking as a risk factor for HIV seroconversion among injection drug users in Vancouver, Canada. CMAJ 2009; 181(9): 585-589.